OphtalmologyPulseSight to disrupt AMD spacePulseSight Therapeutics SAS was launched on Wednesday, backed by seed financing from Pureos Bioventures and ND Capital. The company introduces a disruptive delivery platform in ophthalmology biotech, … more ➔
vaccineSwiss vaccine developer Limma Tech get CARB-X grantSwiss multivalent vaccine developer LimmaTech Biologics AG has been awarded US$2.2m rom the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X). more ➔
financingCurve Therapeutics raises £40.5m in Series A financingIntracellular cancer target screening specialist Curve Therapeutics Ltd has closed a £40.5m financing led by Pfizer Ventures to advance its preclinical pipeline of small cyclic petides. more ➔
financingPacifico Biolabs raises US$3.3m in pre-seed roundGerman foodtech start-up Pacifico Biolabs has raised US$3.3m to push the development of healthy animal-free, carbon-neutrally produced fish and seafood. more ➔
gene therapyGene therapy supplier MIP Discovery closes £7M Series A financingMIP Discovery Ltd has closed a £7M Series A financing to drive commercialisation of its synthetic affinity reagents in cell and gene therapy. more ➔
cancerVidac Pharma Holding plc reports preclinical proof of principleLondon-based Vidac Pharma Holding plc reported that its Warburg effect blocker VDA-1275 increased efficacy of chemotherapeutics 1000-fold in human organoid cancer models for liver cancer. more ➔
FinancingRoche leads Freenome Inc US$257m financingMulti-omics liquid biospy specialist Freenome Inc. has baged US$254m in a financing round led by Roche AG to fund early cancer detection in 6,200 patients using its AI-guided cancer detection platfo … more ➔
BioplasticsBioplastics production capacity to quadruple by 2028New figures published by the industry association European Bioplastics suggest a sharp increase in the production of sustainable plastics in the next two years and calls for policy support. more ➔
financingAZmed closes €15m Series A financingParis-based AI-based medical imanging specialist AZmed SA has secured a €15min Series A financing led by Maison Worms, Techstars, and Tempact Ventures. more ➔
